glp-1 shortage us FDA restricts non-approved compounded weight loss products Chart: 1 in 8 Americans

Muscle loss slows resting metabolism, increases the risk of weight regain after stopping, and in older patients, significantly impacts physical function and fall risk

Widening the hunt for insulin beyond the pancreas Encouraged by the success achieved with insulin, several researchers began exploring the possibility of extracting insulin from the lining of the duodenum known as the duodenal mucosa

These are reasons that clinical evaluation before starting is not optional, and why full disclosure of your medical history during intake isn't just a formality

Many of the companies have started offering GLP-1 medications for weight loss as demand for these drugs has exploded

Microdosing GLP-1 lacks clinical trial evidence and regulatory approval, making its safety profile unknown

Sometimes its addressing metabolic factors, hormonal issues, or considering interventions that create lasting change